Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease - Inria - Institut national de recherche en sciences et technologies du numérique Access content directly
Journal Articles JAMA Network Open Year : 2022

Dates and versions

hal-03889233 , version 1 (07-12-2022)

Identifiers

Cite

Nicolas Hoertel, David Boulware, Marina Sánchez-Rico, Anita Burgun, Frédéric Limosin. Prevalence of Contraindications to Nirmatrelvir-Ritonavir Among Hospitalized Patients With COVID-19 at Risk for Progression to Severe Disease. JAMA Network Open, 2022, 5 (11), pp.e2242140. ⟨10.1001/jamanetworkopen.2022.42140⟩. ⟨hal-03889233⟩
23 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More